Downregulation of AT-rich interaction domain 2 underlies natural killer cell dysfunction in oral squamous cell carcinoma

被引:2
|
作者
Li, Wei [1 ]
An, Ning [1 ]
Wang, Mingwei [2 ]
Liu, Xiguo [1 ]
Mei, Zhidan [1 ]
机构
[1] Huazhong Univ Sci & Technol, Hubei Canc Hosp, Tongji Med Coll, Dept Head & Neck Surg, 16 Zhuodaoquan S Rd, Wuhan 430079, Hubei, Peoples R China
[2] Huazhong Univ Sci & Technol, Hubei Canc Hosp, Tongji Med Coll, Dept Pathol, Wuhan, Peoples R China
来源
IMMUNOLOGY AND CELL BIOLOGY | 2023年 / 101卷 / 01期
关键词
AT-rich interaction domain 2; cytotoxicity; natural killer cells; oral squamous cell carcinoma; programmed death-1; TISSUE;
D O I
10.1111/imcb.12602
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The immune system plays a significant role in controlling oral squamous cell carcinoma (OSCC) initiation and progression. Natural killer (NK) cells actively participate in antitumor immunity but become dysfunctional or exhausted in the tumor microenvironment. To explore the mechanisms of NK cell dysfunction in OSCC, we characterized the expression and function of AT-rich interaction domain 2 (ARID2) in NK cells in a murine OSCC model. ARID2 was downregulated in tongue NK cells compared with splenic NK cells. Notably, ARID2 was significantly decreased in NK cells with an exhausted phenotype and weakened antitumor function. ARID2 knockdown resulted in the upregulation of programmed cell death protein 1 (PD-1) and downregulation of interferon-gamma (IFN-gamma), tumor necrosis factor (TNF), granzyme B and perforin in NK cells. As a result, ARID2 knockdown impaired NK cell cytotoxicity. Besides, ARID2 overexpression suppressed the expression of PD-1 and lymphocyte-activation gene 3, and promoted the expression of IFN-gamma, TNF, granzyme B and perforin in NK cells which were adoptively transferred into OSCC-bearing mice. Taken together, our study implies that the OSCC microenvironment triggers ARID2 downregulation in intratumoral NK cells. In turn, ARID2 downregulation results in PD-1 upregulation on NK cells and subsequently impairs NK cell cytotoxicity. Therefore, we uncovered a novel mechanism of NK cell dysfunction in OSCC.
引用
收藏
页码:78 / 90
页数:13
相关论文
共 50 条
  • [1] Evaluation of natural killer cell defense in oral squamous cell carcinoma
    Turkseven, Mahiye Reyhan
    Oygur, Tuelin
    ORAL ONCOLOGY, 2010, 46 (05) : E34 - E37
  • [2] Down-regulation of PR/SET domain 10 underlies natural killer cell dysfunction in hepatocellular carcinoma
    Han, Jiantao
    Ke, Chao
    Jiang, Bin
    Zhou, Hongjian
    Xu, Hanbin
    Xie, Xingwang
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2021, 206 (03): : 366 - 377
  • [3] Negative regulation of natural killer cell in tumor tissue and peripheral blood of oral squamous cell carcinoma
    Dutta, Anupam
    Banerjee, Arunabha
    Saikia, Nabajyoti
    Phookan, Jyotirmoy
    Baruah, Munindra Narayan
    Baruah, Shashi
    CYTOKINE, 2015, 76 (02) : 123 - 130
  • [4] Jumonji and AT-Rich Interacting Domain 2 (JARID2) exhibits a tumor-suppressive role in Oral Squamous Cell Carcinoma by modulating tumor progression and metastasis
    Sreeshma, Bhuvanadas
    Mohan, A. Mathan
    Devi, Arikketh
    3 BIOTECH, 2024, 14 (12)
  • [5] Downregulation of ATF2 desensitizes oral squamous cell carcinoma to apoptosis
    Razzouk, SN
    Dolgilevich, SM
    Duffey, DC
    MOLECULAR THERAPY, 2004, 9 : S177 - S177
  • [6] CLINICAL SIGNIFICANCE OF ANNEXIN A2 DOWNREGULATION IN ORAL SQUAMOUS CELL CARCINOMA
    Rodrigo, Juan P.
    Lequerica-Fernandez, Paloma
    Rosado, Pablo
    Allonca, Eva
    Garcia-Pedrero, Juana M.
    de Vicente, Juan C.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2011, 33 (12): : 1708 - 1714
  • [7] Natural killer cell trafficking dysfunction in hepatocellular carcinoma
    Missale, G.
    Carone, C.
    Canetti, D.
    Regina, V.
    Capizzuto, V.
    Olivani, A.
    Dalla Valle, R.
    Ferrari, C.
    Cariani, E.
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (01) : 34 - 34
  • [8] Altered Invariant Natural Killer T cell Subsets and its Functions in Patients with Oral Squamous Cell Carcinoma
    Singh, A. K.
    Shukla, N. K.
    Das, S. N.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2013, 78 (05) : 468 - 477
  • [9] Landscape of natural killer cell activity in head and neck squamous cell carcinoma
    Charap, Andrew J.
    Enokida, Tomohiro
    Brody, Rachel
    Sfakianos, John
    Miles, Brett
    Bhardwaj, Nina
    Horowitz, Amir
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
  • [10] Biological and prognostic significance of NDRG2 downregulation in oral squamous cell carcinoma
    Ahn, Chi-Hyun
    Kim, Ji-Hoon
    Shim, Hye-Won
    Shin, Wui-Jung
    Cho, Young-Ah
    Yoon, Hye-Jung
    ORAL DISEASES, 2024, 30 (07) : 4287 - 4302